{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T05:22:38Z","timestamp":1787030558261,"version":"build-2736575974"},"reference-count":19,"publisher":"Spandidos Publications","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.3892\/etm.2015.2197","type":"journal-article","created":{"date-parts":[[2015,1,21]],"date-time":"2015-01-21T04:17:10Z","timestamp":1421813830000},"page":"805-810","source":"Crossref","is-referenced-by-count":11,"title":["Comparative proteomic analysis of membranous nephropathy biopsy tissues using quantitative proteomics"],"prefix":"10.3892","volume":"9","author":[{"given":"WEIGUO","family":"SUI","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"RUOHAN","family":"ZHANG","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JIEJING","family":"CHEN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"HUIYAN","family":"HE","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ZHENZHEN","family":"CUI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MINGLIN","family":"OU","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"LI","family":"GUO","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"SHAN","family":"CONG","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"WEN","family":"XUE","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"YONG","family":"DAI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2015,1,21]]},"reference":[{"key":"key20180108125613_b1-etm-09-03-0805","doi-asserted-by":"crossref","first-page":"c60","DOI":"10.1159\/000341116","article-title":"Does treatment with corticosteroids and cyclosporine reduce transglutaminase type 2 expression in the renal tissue of patients with membranous nephropathy?","volume":"121","author":"Papasotiriou","year":"2012","journal-title":"Nephron Clin Pract"},{"key":"key20180108125613_b2-etm-09-03-0805","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa0810457","article-title":"M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy","volume":"361","author":"Beck","year":"2009","journal-title":"N Engl J Med"},{"key":"key20180108125613_b3-etm-09-03-0805","doi-asserted-by":"crossref","first-page":"3038","DOI":"10.1021\/pr060122b","article-title":"Serial changes in urinary proteome profile of membranous nephropathy: implications for pathophysiology and biomarker discovery","volume":"5","author":"Ngai","year":"2006","journal-title":"J Proteome Res"},{"key":"key20180108125613_b4-etm-09-03-0805","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1002\/prca.200800036","article-title":"Biomarker discovery in glomerular diseases using urinary proteomics","volume":"2","author":"Thongboonkerd","year":"2008","journal-title":"Proteomics Clin Appl"},{"key":"key20180108125613_b5-etm-09-03-0805","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1097\/00041552-200411000-00013","article-title":"Renal biopsy: update","volume":"13","author":"Whittier","year":"2004","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"key20180108125613_b6-etm-09-03-0805","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.jchromb.2006.09.004","article-title":"Global and targeted quantitative proteomics for biomarker discovery","volume":"847","author":"Veenstra","year":"2007","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"key20180108125613_b7-etm-09-03-0805","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1177\/153537020523001105","article-title":"Proteomics as a tool for clinically relevant biomarker discovery and validation","volume":"230","author":"Duncan","year":"2005","journal-title":"Exp Biol Med (Maywood)"},{"key":"key20180108125613_b8-etm-09-03-0805","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/1477-5956-9-22","article-title":"Periostin identified as a potential biomarker of prostate cancer by iTRAQ-proteomics analysis of prostate biopsy","volume":"9","author":"Sun","year":"2011","journal-title":"Proteome Sci"},{"key":"key20180108125613_b9-etm-09-03-0805","doi-asserted-by":"crossref","first-page":"3537","DOI":"10.1007\/s00296-011-2207-1","article-title":"Differential proteomic analysis of renal tissue in lupus nephritis using iTRAQ reagent technology","volume":"32","author":"Sui","year":"2012","journal-title":"Rheumatol Int"},{"key":"key20180108125613_b10-etm-09-03-0805","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1021\/pr049821j","article-title":"Search for cancer markers from endometrial tissues using differentially labeled tags iTRAQ and cICAT with multidimensional liquid chromatography and tandem mass spectrometry","volume":"4","author":"DeSouza","year":"2005","journal-title":"J Proteome Res"},{"key":"key20180108125613_b11-etm-09-03-0805","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1074\/mcp.M700500-MCP200","article-title":"Discovery and verification of head-and-neck cancer biomarkers by differential protein expression analysis using iTRAQ labeling, multidimensional liquid chromatography, and tandem mass spectrometry","volume":"7","author":"Ralhan","year":"2008","journal-title":"Mol Cell Proteomics"},{"key":"key20180108125613_b12-etm-09-03-0805","doi-asserted-by":"crossref","first-page":"3028","DOI":"10.1111\/j.1742-4658.2010.07712.x","article-title":"Comparison of membrane fraction proteomic profiles of normal and cancerous human colorectal tissues with gel-assisted digestion and iTRAQ labeling mass spectrometry","volume":"277","author":"Chen","year":"2010","journal-title":"FEBS J"},{"key":"key20180108125613_b13-etm-09-03-0805","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1093\/ndt\/gfs379","article-title":"Low- and high-molecular-weight urinary proteins as predictors of response to rituximab in patients with membranous nephropathy: a prospective study","volume":"28","author":"Irazabal","year":"2013","journal-title":"Nephrol Dial Transplant"},{"key":"key20180108125613_b14-etm-09-03-0805","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1007\/s00296-010-1625-9","article-title":"Comparative proteome analysis of peripheral blood mononuclear cells in systemic lupus erythematosus with iTRAQ quantitative proteomics","volume":"32","author":"Wang","year":"2012","journal-title":"Rheumatol Int"},{"key":"key20180108125613_b15-etm-09-03-0805","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1159\/000058401","article-title":"Predominance of type-2 immune response in idiopathic membranous nephropathy. Cytoplasmic cytokine analysis","volume":"91","author":"Hirayama","year":"2002","journal-title":"Nephron"},{"key":"key20180108125613_b16-etm-09-03-0805","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1681\/ASN.2009121220","article-title":"Antigen identification in membranous nephropathy moves toward targeted monitoring and new therapy","volume":"21","author":"Ronco","year":"2010","journal-title":"J Am Soc Nephrol"},{"key":"key20180108125613_b17-etm-09-03-0805","doi-asserted-by":"crossref","first-page":"3207","DOI":"10.4049\/jimmunol.138.10.3207","article-title":"The interleukin 1 gene is expressed by rat glomerular mesangial cells and is augmented in immune complex glomerulonephritis","volume":"138","author":"Werber","year":"1987","journal-title":"J Immunol"},{"key":"key20180108125613_b18-etm-09-03-0805","doi-asserted-by":"crossref","first-page":"2546","DOI":"10.1093\/ndt\/gfn007","article-title":"Beta-2-microglobulin is superior to N-acetyl-beta-glucosaminidase in predicting prognosis in idiopathic membranous nephropathy","volume":"23","author":"Hofstra","year":"2008","journal-title":"Nephrol Dial Transplant"},{"key":"key20180108125613_b19-etm-09-03-0805","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1681\/ASN.2004040287","article-title":"Urinary excretion of beta2-microglobulin and IgG predict prognosis in idiopathic membranous nephropathy: a validation study","volume":"16","author":"Branten","year":"2005","journal-title":"J Am Soc Nephrol"}],"container-title":["Experimental and Therapeutic Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/etm.2015.2197\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T02:25:58Z","timestamp":1690856758000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/etm.2015.2197"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1,21]]},"references-count":19,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2015,1,21]]},"published-print":{"date-parts":[[2015,3]]}},"alternative-id":["10.3892\/etm.2015.2197"],"URL":"https:\/\/doi.org\/10.3892\/etm.2015.2197","relation":{},"ISSN":["1792-0981","1792-1015"],"issn-type":[{"value":"1792-0981","type":"print"},{"value":"1792-1015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,1,21]]}}}